The corporate mission at MEDOVEX is to build a market leading portfolio of medical technology companies with FDA approved, revenue generating technologies and products in some of the largest market opportunity segments today and in the future through a development and acquired business company model.

Our focus includes, but is not limited to:

• Osteoarthritis
• Cardiovascular
• Stroke
• Diabetes
• Infection control

The company will offer an unprecedented breadth and depth of innovative therapies in these areas that fulfill our mission of delivering value for all stakeholders to include the patient, provider, insurer and investors. Our mission of “Better Living Through Better Living” means:

• Better medical delivery for providers
• Better clinical outcomes for patients
• Better cost efficiency for the healthcare system

Better opportunities for investors